• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

Insera Therapeutics wins CE Mark for Clear thrombectomy device

April 10, 2019 By Danielle Kirsh

insera-therapeuticsInsera Therapeutics (Sacramento, Calif.) recently announced that it has received CE Mark approval for its Clear Aspiration System.

The system is designed for blood clots and has been indicated for use in patients who have acute ischemic stroke secondary to intracranial large vessel occlusive disease, secondary to cerebral venous sinus thrombosis and for staged aspiration through a balloon guide or guide catheter in neck arteries. It features varying vacuum suction pressures and intervals in a safe vacuum suction range up to -98.2 kPa.

A recent study has shown that complete clot ingestion with cyclical aspiration increases the first-pass recanalization and reduces clot fragmentation when using the Clear Aspiration System.

“The Clear Aspiration System includes a best-in-class, next-generation vacuum aspiration system that allows operators to employ uniform suction or cyclical suction patterns. The digital pump is powerful, easy-to-use and can be operated remotely from an iPad, giving it an advantage over its competitors,” said Dr. Adnan Siddiqui, a doctor at Jacobs Institute’s Chief Medical Officer and SUNY at Buffalo Professor of Neurosurgery who performed the catheterizations.

The system has received CE Mark approval for the aspiration of tissue and fluids, as well as blood clots. It is indicated for use in patients with hemorrhagic stroke or brain bleeds, controlled aspiration of tissue and fluid during ventricular system or cerebrum surgery. It has also been approved for use during neurosurgical, neuro-endoscopic and other surgical procedures.

“Clear’s proprietary power electronics technology for vacuum aspiration allows for the customization of both uniform and variable suction pressures within the safe vacuum suction range, all with an eye towards improving complete clot ingestion and a higher first-pass effect,” Vikram Janardhan, CEO of Insera Therapeutics, said in a press release.

Filed Under: Catheters Tagged With: inseratherapeutics, medtech

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS